AT-6616

N/A

Report date: 2025/12/12 15:31:08
NME

Base Information

Drug NameAT-6616
Drug Alias NameAT-6616AT6616
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAtrial Fibrillation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAtom Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAtom Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsAtrial Fibrillation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A